Early Cannulation Prosthetic Graft (Flixene™) for Arteriovenous Access

Schild, A. Frederick; Schuman, Earl; Noicely, Karlene; Kaufman, Joyce; Gillaspie, Erin A.; Fuller, Joseph C.; Collier, Patrick S.; Ronfeld, Amy; Nair, Rakesh Ravikumaran

doi:10.5301/jva.2011.6351

Cited by 56 publications

(56 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They may offer a large surface area for cannulation. AVGs can be cannulated about 2-3 wk after placement, although there are studies suggesting that immediate assessment after placement for PTFE AVGs is possible [70,71] . This interval is needed in order to allow the surrounding tissue to adhere to the PTFE conduit, to reduce the postsurgical edema and the risk for local complications, such as perigraft hematoma and seroma [72] .…”

Section: Permanent Vamentioning

confidence: 99%

Vascular access today

Pantelias

Grapsa²

2012

WJN

View full text Add to dashboard Cite

The number of patients with chronic kidney disease requiring renal replacement therapy has increased worldwide. The most common replacement therapy is hemodialysis (HD). Vascular access (VA) has a key role for successful treatment. Despite the advances that have taken place in the field of the HD procedure, few things have changed with regards to VA in recent years. Arteriovenous fistula (AVF), polytetrafluoroethylene graft and the cuffed double lumen silicone catheter are the most common used for VA. In the long term, a number of complications may present and more than one VA is needed during the HD life. The most common complications for all of VA types are thrombosis, bleeding and infection, the most common cause of morbidity in these patients. It has been estimated that VA dysfunction is responsible for 20% of all hospitalizations. The annual cost of placing and looking after dialysis VA in the United States exceeds 1 billion dollars per year. A good functional access is also vital in order to deliver adequate HD therapy. It seems that the native AVF that Brescia and Cimino described in 1966 still remains the first choice for VA. The native forearm AVFs have the longest survival and require the fewest interventions. For this reason, the forearm AVF is the first choice, followed by the upper-arm AVF, the arteriovenous graft and the cuffed central venous catheter is the final choice. In conclusion, VA remains the most important issue for patients on HD and despite the technical improvements, a number of problems and complications have to be resolved.

show abstract

Section: Permanent Vamentioning

confidence: 99%

Vascular access today

Pantelias

Grapsa²

2012

WJN

View full text Add to dashboard Cite

show abstract

“…Abb. 1) [2,3]. Beim Verlust der Schlingenfistel besteht die Option, auf eine native Fistel zu wechseln.…”

Section: Die Meinungen Der Leser Zum Fallunclassified

Shuntchirurgisches Kaleidoskop: Lösung zum Fall Nummer 1

Widmer

Kissling

2015

Gefässchirurgie

View full text Add to dashboard Cite

“…Is there a role for an early-stick prosthetic graft as a bridge until the patient has a mature and functional fistula? Thirty-three patients who received an early-stick prosthetic graft were prospectively followed (32). Although primary patency was only 49% at 6 months, it was noted that all grafts were uneventfully accessed for dialysis no later than 72 hours postcreation and in almost 90%, within 24 hours.…”

Section: Bridge and Opportunity For Secondary Fistulae In Incident Pamentioning

confidence: 99%

Interventional Nephrology

Urbanes¹

2013

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

SummaryThe patient's vascular access is critical in ensuring that hemodialysis is successful, effective, relatively uncomplicated, and consistently reproducible from one treatment to another. The choice of vascular access is dictated by a multitude of factors, some of which are generalizable to a larger system, and others of which are flavored by local experience and expertise; an important fraction is specific to the patient presenting to the clinician at a particular point in time. Some of these factors, such as patient age and sex, are not modifiable; others, like comorbidity, vessel size and urgency of presentation to the renal provider, are manageable and sometimes modifiable. The role of the autologous arteriovenous fistula as the ideal conduit for hemodialysis treatments is well established. The role of the prosthetic graft warrants discussion and investigation to most optimally apply to patients this important alternative within the armamentarium of vascular access.

show abstract

Early Cannulation Prosthetic Graft (Flixene™) for Arteriovenous Access

Cited by 56 publications

References 18 publications

Vascular access today

Vascular access today

Shuntchirurgisches Kaleidoskop: Lösung zum Fall Nummer 1

Interventional Nephrology

Contact Info

Product

Resources

About